Chase Investment Counsel’s BrightSpring Health Services BTSG Stock Holding History

Chase Investment Counsel’s Portfolio BTSG Stock Details BTSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.26M	Buy	+193,760	New	+$7.81M	2.17%	14

Other funds holding BTSG

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Chase Investment Counsel's BTSG Position: Q1 2026 in Review

Chase Investment Counsel opened a new position in BrightSpring Health Services (BTSG) in Q1 2026: 193,760 shares worth $8.26M. The stake represents 2.17% of the portfolio and ranks #14 among its holdings.

335 funds tracked by Wall St. Rank hold BTSG as of Q1 2026.

Chase Investment Counsel held 193,760 shares of BrightSpring Health Services worth $8.26M as of Q1 2026.
BrightSpring Health Services was a new Chase Investment Counsel position in Q1 2026.
BrightSpring Health Services made up 2.17% of Chase Investment Counsel's portfolio in Q1 2026, its #14 holding.
335 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q1 2026.

Based on Chase Investment Counsel's 13F filing for Q1 2026, filed 12 May 2026.